BioMérieux financial update: Overview of share capital and voting rights in April 2024

In its latest press release, the company bioMérieux, specializing in in vitro diagnostics, revealed the figures relating to share capital and voting rights as of April 30, 2024. According to the document, the total number of shares amounts to 118,361 220. This figure is crucial for investors and shareholders, reflecting the basis of the company's capital structure.

bioMérieux also announced that the total number of theoretical voting rights reaches 190,940,049. This information is essential for understanding voting potential in important company decisions. These voting rights are calculated in accordance with the regulations of the Financial Markets Authority, including all shares, even those without voting rights.